Zhixin Shu, CFA

B.Sc. and PhD in Chemistry, Imperial College of Science and Technology,
MBA University of Ottawa

• 12 years investment experience
• Responsible for research in Asia equities specialising in Greater China
• Previously worked for Morgan Stanley, Newton Investment Management, National Research Council of Canada and Ottawa Heart Institute Canada

Zhixin joined Rexiter in June 2007 and has responsibilities in equity research for Greater China.   Prior to joining Rexiter, Zhixin worked for 10 years as a fund manager/equity analyst in European equities at Morgan Stanley and as a sector analyst in global equities (pharmaceuticals, biotechnology, energy and chemicals) at Newton Investment Management.  Previously, Zhixin worked primarily in Canada at various research institutes on subjects ranging from coal and oil, to the development of an artificial heart to advanced materials for batteries, an area in which she has been awarded two US patents.